Advertisement
Researchers Have Identified What Causes Alzheimer's To Progress In The Brain
Nearly 6 million Americans are living with Alzheimer's1, and despite the overwhelming presence and detrimental effect of the disease, researchers have not been able to accurately determine how it advances. Until now, that is.
A study published in the peer-reviewed journal Science Advances was the first to use human data, rather than animal studies, to identify the cause of Alzheimer's progression in the brain2.
What causes Alzheimer's to progress?
Before diving in, it's helpful to know that there are two proteins involved in the cognitive decline of Alzheimer's disease: amyloid-beta and tau. The buildup of these proteins is called aggregates, and they are responsible for memory loss, personality changes, and ultimately the killing of brain cells3.
Until now, researchers thought the disease progressed by spreading from one region of the brain to another "in a way that's similar to many cancers," lead study author Georg Meisl, Ph.D., said in a news release.
By using brain samples from deceased Alzheimer's patients and PET scans from living patients with varying progressions of the disease, researchers were able to track how tau aggregates actually develop.
What they discovered is that rather than spreading over time, tau aggregates already exist in multiple regions of the brain at the onset. "So trying to stop the spread between regions will do little to slow the disease," Meisl explains.
What does this mean for the treatment of Alzheimer's?
While there's still no treatment for the neurodegenerative disease, this study leads researchers one step closer to understanding it. "The key discovery is that stopping the replication of aggregates rather than their propagation is going to be more effective at the stages of the disease that we studied," notes study co-author Tuomas Knowles, Ph.D.
In other good news, researchers found the replication of tau aggregates is actually quite slow—about five years on average. "Neurons are surprisingly good at stopping aggregates from forming," says co-author and dementia researcher Sir David Klenerman, "but we need to find ways to make them even better if we're going to develop an effective treatment."
The takeaway
While there's no treatment for Alzheimer's disease, new technology is making more accurate research possible so scientists can get one step closer. In the meantime, people can take some preventive measures, such as these neurologists' tips for combating cognitive decline at every age or potentially adding more amino acids to your diet.
Watch Next
Enjoy some of our favorite clips from classes
Enjoy some of our favorite clips from classes
What Is Meditation?
Mindfulness/Spirituality | Light Watkins
Box Breathing
Mindfulness/Spirituality | Gwen Dittmar
What Breathwork Can Address
Mindfulness/Spirituality | Gwen Dittmar
The 8 Limbs of Yoga - What is Asana?
Yoga | Caley Alyssa
Two Standing Postures to Open Up Tight Hips
Yoga | Caley Alyssa
How Plants Can Optimize Athletic Performance
Nutrition | Rich Roll
What to Eat Before a Workout
Nutrition | Rich Roll
How Ayurveda Helps Us Navigate Modern Life
Nutrition | Sahara Rose
Messages About Love & Relationships
Love & Relationships | Esther Perel
Love Languages
Love & Relationships | Esther Perel
What Is Meditation?
Box Breathing
What Breathwork Can Address
The 8 Limbs of Yoga - What is Asana?
Two Standing Postures to Open Up Tight Hips
How Plants Can Optimize Athletic Performance
What to Eat Before a Workout
How Ayurveda Helps Us Navigate Modern Life
Messages About Love & Relationships
Love Languages
Advertisement
The Sleep Routine That Helps Me Spend Up To 25% Of The Night In REM Sleep
Jill Carnahan, MD ABIHM, ABoIM, IFMCP
The Sleep Routine That Helps Me Spend Up To 25% Of The Night In REM Sleep
Jill Carnahan, MD ABIHM, ABoIM, IFMCP
The Sleep Routine That Helps Me Spend Up To 25% Of The Night In REM Sleep
Jill Carnahan, MD ABIHM, ABoIM, IFMCP
The Sleep Routine That Helps Me Spend Up To 25% Of The Night In REM Sleep
Jill Carnahan, MD ABIHM, ABoIM, IFMCP